EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States

Puja H Nambiar, Tao Liang iD, Nazzarena Labo iD, Jonathan Hand iD, Emily A Blumberg iD, Meenakshi M Rana, Sander Florman, Brandy Haydel iD, Michele I Morris iD, Joanna Schaenman, Moreno M S Rodrigues, William A Werbel iD und 27 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf229 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Puja H Nambiar und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Kidney Transplantation, HIV Infections, Transplant Recipients. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to high prevalence of Kaposi sarcoma–associated herpesvirus (KSHV) among people with human immunodeficiency virus (HIV), KSHV-associated disease (KAD) may be increased after kidney transplantation from donors with HIV (HIV D+) to recipients with HIV (HIV R+).

Methods

Anti-KSHV antibodies were measured in HIV R+ and donors with and without HIV (HIV D–) using a 30-antigen multiplex assay within 3 multicenter kidney transplantation studies. KSHV seropositivity was defined as reactivity to conventional KSHV antigens (≥1 ORF73 or K8.1); reactivity to expanded 5-antigen and 30-antigen panels were also reported. Risk factors were identified using modified Poisson regression. Recipients were monitored for posttransplant anti-KSHV antibody changes and KAD.

Results

KSHV seroprevalence was 40.6% (143/352) among HIV R+, 25.2% (33/131) among HIV D+, and 7.5% (4/53) among HIV D–. In the multivariable model, only men who have sex with men (MSM) status was associated with KSHV seropositivity (relative risk, 1.51 [95% confidence interval {CI}, 1.07–2.14] in recipients and 2.39 [95% CI, 1.03–5.53] in donors). Among 418 HIV R+ (215 HIV D+/R+, 203 HIV D–/R+), there were 5 KAD cases (incidence, 0.63 cases/100 person-years [95% CI, .26–1.52]): 3 skin-only Kaposi sarcoma (KS), 1 multicentric Castleman disease, and 1 allograft KS. The allograft KS occurred in a female HIV D+/R+ and was likely donor derived. Remaining KAD cases occurred in male HIV D–/R+ and were likely recipient KSHV reactivation or acquisition.

Conclusions

In the United States, KSHV seroprevalence in donors and recipients with HIV was high, particularly among MSM. Reassuringly, KSHV-associated disease was rare and primarily attributed to recipient rather than donor-derived KSHV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanKidney TransplantationHIV InfectionsTransplant RecipientsTissue DonorsSarcoma, KaposiHerpesviridae InfectionsHumansMaleFemaleUnited StatesMiddle AgedAdultSeroepidemiologic StudiesRisk FactorsAntibodies, Viral

Stichwörter der Autor:innen

HIVHOPE ActKSHV seroprevalenceKaposi sarcomahuman herpesvirus 8

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Department of Medicine, Ochsner Health, New Orleans, Louisiana, USA.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Tao Liang, Nazzarena Labo, Jonathan Hand, Emily A Blumberg, Brandy Haydel, Michele I Morris, William A Werbel, Valentina Stosor, Alexander J Gilbert, Nahel Elias, Maricar Malinis, David Wojciechowski, Ricardo La Hoz, Carlos A Q Santos, Allan Massie, Dorry L Segev, Vickie Marshall, Denise Whitby, Christine M Durand

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NCI NIH HHS
  • Johns Hopkins School of Medicine Discovery Fund for Synergy
  • The Living Legacy Foundation
  • National Institutes of Health

Zitieren

APA

Nambiar, P. H., Liang, T., Labo, N., Hand, J., Blumberg, E. A., Rana, M. M., Florman, S., Haydel, B., Morris, M. I., Schaenman, J., Rodrigues, M. M. S., Werbel, W. A., Bowring, M. G., Friedman-Moraco, R. J., Stock, P., Stosor, V., Mehta, S., Gilbert, A. J., Elias, N., …, & Durand, C. M. (2026). Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf229

Vancouver

Nambiar PH, Liang T, Labo N, Hand J, Blumberg EA, Rana MM, et al. Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf229

BibTeX
@article{Nambiar2026,
  author = {Nambiar, Puja H and Liang, Tao and Labo, Nazzarena and Hand, Jonathan and Blumberg, Emily A and Rana, Meenakshi M and Florman, Sander and Haydel, Brandy and Morris, Michele I and Schaenman, Joanna and Rodrigues, Moreno M S and Werbel, William A and Bowring, Mary G and Friedman-Moraco, Rachel J and Stock, Peter and Stosor, Valentina and Mehta, Shikha and Gilbert, Alexander J and Elias, Nahel and Mehta, Sapna A and Small, Catherine B and Haidar, Ghady and Malinis, Maricar and Pereira, Marcus R and Aslam, Saima and Wojciechowski, David and La Hoz, Ricardo and Santos, Carlos A Q and Apewokin, Senu and Castillo-Lugo, Jose A and Ranganna, Karthik and Morsheimer, Megan and Massie, Allan and Segev, Dorry L and Miley, Wendell and Marshall, Vickie and Whitby, Denise and Tobian, Aaron A A and Durand, Christine M},
  title = {Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf229}
}
Kostenlos starten →